{"count": 10, "results": [{"_id": "37969194", "pmid": 37969194, "title": "Metformin ameliorates insulin resistance, thyroid nodules and thyroid function.", "journal": "Am J Transl Res", "authors": ["Ji S", "Gao R", "Gao Q", "Leng L", "Gai N"], "date": "2023-10-15T00:00:00Z", "meta_date_publication": "2023", "meta_volume": "15", "meta_issue": "10", "meta_pages": "6180-6188", "score": 50269.145, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@, @<m>DISEASE_Thyroid_Nodule</m> @DISEASE_MESH:D016606 @@@thyroid nodules@@@ and thyroid function.", "citations": {"NLM": "Ji S, Gao R, Gao Q, Leng L, Gai N. Metformin ameliorates insulin resistance, thyroid nodules and thyroid function. Am J Transl Res. 2023;15(10):6180-6188. PMID: 37969194", "BibTeX": "@article{37969194, title={Metformin ameliorates insulin resistance, thyroid nodules and thyroid function.}, author={Ji S and Gao R and Gao Q and Leng L and Gai N}, journal={Am J Transl Res}, volume={15}, number={10}, pages={6180-6188}}"}}, {"_id": "33058005", "pmid": 33058005, "pmcid": "PMC8195970", "title": "TSH lowering effects of metformin: a possible mechanism of action", "journal": "J Endocrinol Invest", "authors": ["Cannarella R", "Condorelli RA", "Barbagallo F", "Aversa A", "Calogero AE", "La Vignera S"], "date": "2021-07-01T00:00:00Z", "doi": "10.1007/s40618-020-01445-9", "meta_date_publication": "2021 Jul", "meta_volume": "44", "meta_issue": "7", "meta_pages": "1547-1550", "score": 50258.707, "text_hl": "Also, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may exert a protective role against @<m>DISEASE_Thyroid_Nodule</m> @DISEASE_MESH:D016606 @@@thyroid nodules@@@ growth in @SPECIES_9606 @@@patients@@@ without @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin-resistance@@@. ", "citations": {"NLM": "Cannarella R, Condorelli RA, Barbagallo F, Aversa A, Calogero AE, La Vignera S. TSH lowering effects of metformin: a possible mechanism of action J Endocrinol Invest. 2021 Jul;44(7):1547-1550. PMID: 33058005", "BibTeX": "@article{33058005, title={TSH lowering effects of metformin: a possible mechanism of action}, author={Cannarella R and Condorelli RA and Barbagallo F and Aversa A and Calogero AE and La Vignera S}, journal={J Endocrinol Invest}, volume={44}, number={7}, pages={1547-1550}}"}}, {"_id": "35454163", "pmid": 35454163, "pmcid": "PMC9029304", "title": "Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications", "journal": "Biomolecules", "authors": ["García-Sáenz M", "Lobaton-Ginsberg M", "Ferreira-Hermosillo A"], "date": "2022-04-14T00:00:00Z", "doi": "10.3390/biom12040574", "meta_date_publication": "2022 Apr 14", "meta_volume": "12", "meta_issue": "4", "meta_pages": "", "score": 50252.766, "text_hl": "Sui et al. conducted a systematic review and meta-analysis that included 7 studies with 240 @SPECIES_9606 @@@patients@@@ evaluating the relationship between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy and reduction on @<m>DISEASE_Thyroid_Nodule</m> @DISEASE_MESH:D016606 @@@thyroid nodules@@@. ", "citations": {"NLM": "García-Sáenz M, Lobaton-Ginsberg M, Ferreira-Hermosillo A. Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications Biomolecules. 2022 Apr 14;12(4):. PMID: 35454163", "BibTeX": "@article{35454163, title={Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications}, author={García-Sáenz M and Lobaton-Ginsberg M and Ferreira-Hermosillo A}, journal={Biomolecules}, volume={12}, number={4}}"}}, {"_id": "30233494", "pmid": 30233494, "pmcid": "PMC6127618", "title": "Efficacy of Metformin for Benign Thyroid Nodules in Subjects With Insulin Resistance: A Systematic Review and Meta-Analysis", "journal": "Front Endocrinol (Lausanne)", "authors": ["Sui M", "Yu Y", "Zhang H", "Di H", "Liu C", "Fan Y"], "date": "2018-08-28T00:00:00Z", "doi": "10.3389/fendo.2018.00494", "meta_date_publication": "2018", "meta_volume": "9", "meta_issue": "", "meta_pages": "494", "score": 50088.914, "text_hl": "Some negative or irrelevance results related to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment for @<m>DISEASE_Thyroid_Nodule</m> @DISEASE_MESH:D016606 @@@thyroid nodule@@@ volume might not be published. ", "citations": {"NLM": "Sui M, Yu Y, Zhang H, Di H, Liu C, Fan Y. Efficacy of Metformin for Benign Thyroid Nodules in Subjects With Insulin Resistance: A Systematic Review and Meta-Analysis Front Endocrinol (Lausanne). 2018;9():494. PMID: 30233494", "BibTeX": "@article{30233494, title={Efficacy of Metformin for Benign Thyroid Nodules in Subjects With Insulin Resistance: A Systematic Review and Meta-Analysis}, author={Sui M and Yu Y and Zhang H and Di H and Liu C and Fan Y}, journal={Front Endocrinol (Lausanne)}, volume={9}, pages={494}}"}}, {"_id": "25657744", "pmid": 25657744, "pmcid": "PMC4310072", "title": "Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes: A randomized placebo-controlled clinical trial", "journal": "J Res Med Sci", "authors": ["Karimifar M", "Aminorroaya A", "Amini M", "Mirfendereski T", "Iraj B", "Feizi A", "Norozi A"], "date": "2014-11-01T00:00:00Z", "meta_date_publication": "2014 Nov", "meta_volume": "19", "meta_issue": "11", "meta_pages": "1019-26", "score": 50074.395, "text_hl": "In prediabetic people, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ decreases serum TSH, only, in those people with TSH >2.5 muU/ml and reduces the size of small solid @<m>DISEASE_Thyroid_Nodule</m> @DISEASE_MESH:D016606 @@@thyroid nodules@@@. ", "citations": {"NLM": "Karimifar M, Aminorroaya A, Amini M, Mirfendereski T, Iraj B, Feizi A, Norozi A. Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes: A randomized placebo-controlled clinical trial J Res Med Sci. 2014 Nov;19(11):1019-26. PMID: 25657744", "BibTeX": "@article{25657744, title={Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes: A randomized placebo-controlled clinical trial}, author={Karimifar M and Aminorroaya A and Amini M and Mirfendereski T and Iraj B and Feizi A and Norozi A}, journal={J Res Med Sci}, volume={19}, number={11}, pages={1019-26}}"}}, {"_id": "28196954", "pmid": 28196954, "title": "Metformin and thyroid disease.", "journal": "J Endocrinol", "authors": ["Meng X", "Xu S", "Chen G", "Derwahl M", "Liu C"], "date": "2017-04-01T00:00:00Z", "doi": "10.1530/JOE-16-0450", "meta_date_publication": "2017 Apr", "meta_volume": "233", "meta_issue": "1", "meta_pages": "R43-R51", "score": 50065.797, "text_hl": "Accordingly, @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ have a smaller @DISEASE_Thyroiditis @DISEASE_MESH:D013966 @@@thyroid@@@ volume and a lower risk of incident @DISEASE_Goiter @DISEASE_MESH:D006042 @@@goiter@@@, @<m>DISEASE_Thyroid_Nodule</m> @DISEASE_MESH:D016606 @@@thyroid nodule@@@ and @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@. ", "citations": {"NLM": "Meng X, Xu S, Chen G, Derwahl M, Liu C. Metformin and thyroid disease. J Endocrinol. 2017 Apr;233(1):R43-R51. PMID: 28196954", "BibTeX": "@article{28196954, title={Metformin and thyroid disease.}, author={Meng X and Xu S and Chen G and Derwahl M and Liu C}, journal={J Endocrinol}, volume={233}, number={1}, pages={R43-R51}}"}}, {"_id": "21128816", "pmid": 21128816, "title": "Metformin treatment for small benign thyroid nodules in patients with insulin resistance.", "journal": "Metab Syndr Relat Disord", "authors": ["Rezzónico J", "Rezzónico M", "Pusiol E", "Pitoia F", "Niepomniszcze H"], "date": "2011-02-01T00:00:00Z", "doi": "10.1089/met.2010.0026", "meta_date_publication": "2011 Feb", "meta_volume": "9", "meta_issue": "1", "meta_pages": "69-75", "score": 50065.363, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment for small @<m>DISEASE_Thyroid_Nodule</m> @DISEASE_MESH:D016606 @@@benign thyroid nodules@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@.", "citations": {"NLM": "Rezzónico J, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H. Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab Syndr Relat Disord. 2011 Feb;9(1):69-75. PMID: 21128816", "BibTeX": "@article{21128816, title={Metformin treatment for small benign thyroid nodules in patients with insulin resistance.}, author={Rezzónico J and Rezzónico M and Pusiol E and Pitoia F and Niepomniszcze H}, journal={Metab Syndr Relat Disord}, volume={9}, number={1}, pages={69-75}}"}}, {"_id": "30595105", "pmid": 30595105, "title": "Role of Metformin in the Treatment of Patients with Thyroid Nodules and Insulin Resistance: A Systematic Review and Meta-Analysis.", "journal": "Thyroid", "authors": ["He X", "Wu D", "Hu C", "Xu T", "Liu Y", "Liu C", "Xu B", "Tang W"], "date": "2019-03-01T00:00:00Z", "doi": "10.1089/thy.2017.0707", "meta_date_publication": "2019 Mar", "meta_volume": "29", "meta_issue": "3", "meta_pages": "359-367", "score": 50060.23, "text_hl": "Studies evaluating the size of @<m>DISEASE_Thyroid_Nodule</m> @DISEASE_MESH:D016606 @@@thyroid nodules@@@ before and after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment were included. ", "citations": {"NLM": "He X, Wu D, Hu C, Xu T, Liu Y, Liu C, Xu B, Tang W. Role of Metformin in the Treatment of Patients with Thyroid Nodules and Insulin Resistance: A Systematic Review and Meta-Analysis. Thyroid. 2019 Mar;29(3):359-367. PMID: 30595105", "BibTeX": "@article{30595105, title={Role of Metformin in the Treatment of Patients with Thyroid Nodules and Insulin Resistance: A Systematic Review and Meta-Analysis.}, author={He X and Wu D and Hu C and Xu T and Liu Y and Liu C and Xu B and Tang W}, journal={Thyroid}, volume={29}, number={3}, pages={359-367}}"}}, {"_id": "31379740", "pmid": 31379740, "pmcid": "PMC6656339", "title": "Effects of Metformin on TSH Levels and Benign Nodular Goiter Volume in Patients Without Insulin Resistance or Iodine Insufficiency", "journal": "Front Endocrinol (Lausanne)", "authors": ["Dos Santos PB", "Gertrudes LN", "Conceição FL", "de Andrade BM", "de Carvalho DP", "Vaisman M", "Teixeira PFDS"], "date": "2019-07-17T00:00:00Z", "doi": "10.3389/fendo.2019.00465", "meta_date_publication": "2019", "meta_volume": "10", "meta_issue": "", "meta_pages": "465", "score": 50055.18, "text_hl": "Objectives: To evaluate the impact of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MTF@@@) use on TSH levels, thyroid volume and volume of @<m>DISEASE_Thyroid_Nodule</m> @DISEASE_MESH:D016606 @@@benign thyroid nodules@@@ (@<m>DISEASE_Thyroid_Nodule</m> @DISEASE_MESH:D016606 @@@TNs@@@). ", "citations": {"NLM": "Dos Santos PB, Gertrudes LN, Conceição FL, de Andrade BM, de Carvalho DP, Vaisman M, Teixeira PFDS. Effects of Metformin on TSH Levels and Benign Nodular Goiter Volume in Patients Without Insulin Resistance or Iodine Insufficiency Front Endocrinol (Lausanne). 2019;10():465. PMID: 31379740", "BibTeX": "@article{31379740, title={Effects of Metformin on TSH Levels and Benign Nodular Goiter Volume in Patients Without Insulin Resistance or Iodine Insufficiency}, author={Dos Santos PB and Gertrudes LN and Conceição FL and de Andrade BM and de Carvalho DP and Vaisman M and Teixeira PFDS}, journal={Front Endocrinol (Lausanne)}, volume={10}, pages={465}}"}}, {"_id": "26618447", "pmid": 26618447, "pmcid": "PMC5588367", "title": "Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study", "journal": "Med Princ Pract", "authors": ["Anil C", "Kut A", "Atesagaoglu B", "Nar A", "Bascil Tutuncu N", "Gursoy A"], "date": "2016-01-01T00:00:00Z", "doi": "10.1159/000442821", "meta_date_publication": "2016", "meta_volume": "25", "meta_issue": "3", "meta_pages": "233-6", "score": 50050.613, "text_hl": "The mean @<m>DISEASE_Thyroid_Nodule</m> @DISEASE_MESH:D016606 @@@thyroid nodule@@@ size was also significantly decreased after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy (12.9 +- 7.6 vs. 11.7 +- 7.2 mm, p < 0.0001); 65 @SPECIES_9606 @@@patients@@@ had @<m>DISEASE_Thyroid_Nodule</m> @DISEASE_MESH:D016606 @@@thyroid nodules@@@ >=5 mm (satisfying one of the inclusion criteria for admission) at the beginning, which decreased to 56 after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy (p = 0.004). ", "citations": {"NLM": "Anil C, Kut A, Atesagaoglu B, Nar A, Bascil Tutuncu N, Gursoy A. Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study Med Princ Pract. 2016;25(3):233-6. PMID: 26618447", "BibTeX": "@article{26618447, title={Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study}, author={Anil C and Kut A and Atesagaoglu B and Nar A and Bascil Tutuncu N and Gursoy A}, journal={Med Princ Pract}, volume={25}, number={3}, pages={233-6}}"}}]}